ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,032Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 1006

$1.09M Total Retail Price of All Prescriptions

Rank: 32 out of 1006

508 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 508 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,313 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$121 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 624 540 1 2
LISINOPRIL 283 267 2 3
FUROSEMIDE 274 267 3 6
AMLODIPINE BESYLATE 220 218 4 4
ZETIA 197 188 5 51
SIMVASTATIN 193 191 6 1
PRAVASTATIN SODIUM 185 175 7 15
ZOLPIDEM TARTRATE 177 158 8 14
LANTUS SOLOSTAR 176 155 9 93
HYDROCHLOROTHIAZIDE 161 155 10 11
PEN NEEDLE 159 152 11 128
LOSARTAN POTASSIUM 147 129 12 22
METOPROLOL SUCCINATE 147 147 12 12
OMEPRAZOLE 141 109 14 9
ATORVASTATIN CALCIUM 126 122 15 5
NOVOLOG FLEXPEN 121 121 16 190
LANTUS 118 102 17 43
METFORMIN HCL ER 111 101 18 56
INSULIN SYRINGE 110 108 19 122
HUMALOG 107 89 20 116
METOPROLOL TARTRATE 103 102 21 7
LYRICA 99 75 22 115
CITALOPRAM HBR 96 89 23 24
ATENOLOL 85 83 24 13
SYNTHROID 82 65 25 42
ALLOPURINOL 78 72 26 31
TAMSULOSIN HCL 75 75 27 23
HYDROCODONE-ACETAMINOPHEN 73 72 S3 28 25
ISOSORBIDE MONONITRATE ER 73 71 28 59
GLIMEPIRIDE 68 50 30 50
PANTOPRAZOLE SODIUM 67 62 31 32
KLOR-CON M20 67 53 31 70
METHIMAZOLE 67 59 31 333
NEXIUM 65 61 34 28
CEFUROXIME 64 57 35 170
RAMIPRIL 59 59 36 79
MECLIZINE HCL 59 50 36 137
JANUVIA 57 55 38 49
FLUTICASONE PROPIONATE 56 50 39 55
TRAMADOL HCL 56 56 39 35
QUINAPRIL HCL 56 56 39 86
AZITHROMYCIN 55 52 42 39
ADVAIR DISKUS 55 52 42 37
CLOPIDOGREL 53 49 44 46
PREDNISONE 52 43 45 33
LEVEMIR FLEXPEN 52 52 45 173
CARAFATE 50 50 47 275
WELCHOL 50 49 47 222
CIPROFLOXACIN HCL 50 48 47 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.